Centers for Disease Control and Prevention (CDC). About Diabetes. https://www.cdc.gov/diabetes/basics/diabetes.html. Accessed March 17, 2020.
American Diabetes Association (ADA). Statistics About Diabetes. http://diabetes.org/diabetes-basics/statistics/. Accessed October 1, 2019.
Lin, J., Thompson, T.J., Cheng, Y.J. et al. Projection of the future diabetes burden in the United States through 2060. Popul Health Metrics 16, 9 (2018). https://doi.org/10.1186/s12963-018-0166-4
Gregg EW, Hora I, Benoit SR. Resurgence in Diabetes-Related Complications. JAMA. 2019;321(19):1867–1868. doi:https://doi.org/10.1001/jama.2019.3471
Centers for Disease Control and Prevention (CDC). https://www.cdc.gov/media/releases/2014/p0416-diabetes-complications.html. Accessed October 1, 2019.
Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adher 2016; 10: 1299–1307.
Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006;166(17):1836-1841.
Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care 2004;27(9):2149-2153.
Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43(6):521-530.
Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther. 2011;33(1):74-109
DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004;42(3):200-209.
Feldman R, Bacher M, Campbell N, Drover A, Chockalingam A. Adherence to pharmacologic management of hypertension. Can J Public Health 1998;89(5):I16-18.
Avorn J, Monette J, Lacour A, et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA.1998;279(18):1458-1462.
Heisler M, Faul JD, Hayward RA, Langa KM, Blaum C, Weir D. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med 2007;167(17):1853-60.
Trinacty CM, Adams AS, Soumerai SB, et al. Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res 2009;9:24.
Shenolikar RA, Balkrishnan R, Camacho FT, Whitmire JT, Anderson RT. Race and medication adherence in Medicaid enrollees with type-2 diabetes. J Natl Med Assoc 2006;98(7):1071-7
Tseng CW, Tierney EF, Gerzoff RB, et al Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research Into Action for Diabetes Study. Diabetes Care 2008;31(2):261-6.
Peeters B, Van Tongelen I, Boussery K, Mehuys E, Remon JP, Willems S. Factors associated with medication adherence to oral hypoglycaemic agents in different ethnic groups suffering from type 2 diabetes: a systematic literature review and suggestions for further research. Diabet Med 2011;28(3):262-75.
Duru OK, Gerzoff RB, Selby JV, et al. Identifying risk factors for racial disparities in diabetes outcomes: the translating research into action for diabetes study. Med Care 2009;47(6):700-6.
van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res 2007;7:55.
McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288(22):2868-2879.
Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296(21):2563-71.
Duru OKK, Schmittdiel J, Dyer W, et al. Mail order pharmacy use and adherence to diabetes-related medications. Am J Manag Care 2010;16(1):33-40.
Schmittdiel J, Karter A, Dyer W, et al. The comparative effectiveness of mail order pharmacy vs. local pharmacy use on LDL-C control in new statin users. J Gen Intern Med 2011; 1396-402.
Sharma KP, Taylor TN. Pharmacy effect on adherence to antidiabetic medications. Med Care 2012;50:685-691.
Zhang L, Zakharyan A, Stockl KM, Harada ASM, Curtis BS, Solow BK. Mail-order pharmacy use and medication adherence among Medicare Part D beneficiaries with diabetes. J Med Econ, 2011;14(5):562-567.
Devine S, Vlahiotis A, Sundar H. A comparison of diabetes medication adherence and healthcare costs in patients using mail order pharmacy and retail pharmacy. J Med Econ, 2010;(2):203-2011.
Fernandez E, McDaniel JA, Carroll NV. Examination of the link between medication adherence and use of mail-order pharmacies in chronic disease status. J Manag Care Spec Pharm 2016;22(11):1247-59.
Johnsrud M, Lawsen KA, Shepherd MD. Comparison of mail order with community pharmacy in plan sponsor cost and member cost in two large pharmacy benefit plans. J Manag Care Pharm, 2007; 13(2):122-34.
Carroll NV, Brusilovsky I, York B, Oscar R. Comparison of costs of community and mail service pharmacy. JAM Pharm Assoc 2003;45(3):336-343.
Centers for Disease Control and Prevention (CDC). Coronavirus Disease 2019. https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/high-risk-complications.html. Accessed March 12, 2020.
Karter AJ, Parker MM, Duru KO, et al. Impact of a pharmacy benefit change on new use of mail order pharmacy among diabetes patients: The Diabetes Study of Northern California (DISTANCE). Health Serv Res 2015;50(2):537-59.
Schmittdiel JA, Marshall CJ,Wiley D, et al. Opportunities to Encourage Mail Order Pharmacy Use in Diabetes—A Qualitative Study. Diabetes 2018, 67 (Supplement 1).
Marsha A. Raebel, Schmittdiel JA, et al. Standardizing Terminology and Definitions of Medication Adherence and Persistence in Research employing Electronic Databases. Med Care. 2013; 51(8 0 3): S11–S21.
Schmittdiel JA, Adams SR, Goler N, et al. The impact of telephonic wellness coaching on weight loss: A “Natural Experiments for Translation in Diabetes (NEXT-D)” study. Obesity (Silver Spring) 2017;25(2):352–356.
Schwab, Phil, et al. A Retrospective Database Study Comparing Diabetes-Related Medication Adherence and Health Outcomes for Mail-Order Versus Community Pharmacy. J Manag Care Specialty Pharm 2019; 25(3):332-340.
Adams AS, Uratsu C, Dyer W, et al. Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users. JAMA Intern Med 2013; 173(1):54-61.
Liberman JN, Wang Y, Hutchins DS, Slezak J, Shrank WH. Revealed preference for community and mail service pharmacy. J Am Pharm Assoc (2003). 2011;51(1):50-7.
Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost sharing among poor and elderly persons. JAMA. 2001;285(4):421-9.
Chernew M, Gibson TB, Yu-Isenberg K, Sokol MC, Rosen AB, Fendrick AM. Effects of increased patient cost sharing on socioeconomic disparities in health care. J Gen Intern Med 2008;23(8):1131-6.
Osborn CY, Cavanaugh K, Wallston KA, et al. Health literacy explains racial disparities in diabetes medication adherence. J Health Commun 2011;16 Suppl 3:268-78.
Lewis LM, Ogedegbe C, Ogedegbe G. Enhancing adherence of antihypertensive regimens in hypertensive African-Americans: current and future prospects. Expert Rev Cardiovasc Ther 2012;10(11):1375-80.
Schoenthaler A, Allegrante JP, Chaplin W, Ogedegbe G. The effect of patient-provider communication on medication adherence in hypertensive black patients: does race concordance matter? Ann Behav Med 2012;43(3):372-82.
Saha S, Freeman M, Toure J, Tippens KM, Weeks C, Ibrahim S. Racial and ethnic disparities in the VA health care system: a systematic review. J Gen Intern Med 2008;23(5):654-71.
Nichols GA, Bell TJ, Pedula KL, O’Keeffe-Rosetti M. Medical Care Costs Among Patients With Established Cardiovascular Disease. Am J Manag Care 2010;16(3):e86-93.